Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1984-03-30
1984-10-23
Moyer, Donald B.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
424101, A61K 3702, A61K 3514
Patent
active
044788290
ABSTRACT:
Disclosed are readily reconstitutable lyophilized fibronectin formulations containing fibronectin, a neutral salt, a carbohydrate and a surface active agent.
REFERENCES:
patent: 2848529 (1980-05-01), Schwinn et al.
patent: 3057781 (1962-10-01), Mace et al.
patent: 3133001 (1964-05-01), Muset et al.
patent: 3215685 (1965-11-01), Nakanishi et al.
patent: 3607858 (1971-09-01), Querry
patent: 4089944 (1978-05-01), Thomas
patent: 4186192 (1980-01-01), Lundblad et al.
Carter and Hakomori, A New Cell Surface, Detergent-insoluble _Glycoprotein Matrix of Human and Hamster Fibroblasts, J. Biol. Chem., 1981, 256(13), 6953-60, (Chem. Ab., vol. 95, p. 227).
Farb David L.
Landaburu Ricardo H.
Violand Bernard N.
Yue Robert H.
Armour Pharmaceutical Company
Moyer Donald B.
Stone J. M.
LandOfFree
Pharmaceutical preparation containing purified fibronectin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical preparation containing purified fibronectin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical preparation containing purified fibronectin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1598666